Milestone Pharmaceuticals
Focus: Milestone Pharmaceuticals is a small-molecule focused company headquartered in Montreal, Canada, specializing in neurology and cardiovascular therapies with a recently launched nasal spray formulation.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Open Jobs
3+1 this month
Stable — net +1 jobs in 30d
4 added, 3 removed. Backfill posture.
Should You Work at Milestone Pharmaceuticals?
AI assessmentEarly-stage execution risk with a commercial product, suitable only for candidates seeking launch-phase experience and tolerant of uncertainty.
Why Work Here
- Recently achieved FDA approval and commercial launch of CARDAMYST (etripamil), offering exposure to a product in active market penetration phase
- Focused pipeline with multiple Phase 3 trials underway for PSVT and atrial fibrillation, providing clear near-term catalysts
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Launch16.2yr
First-in-class nasal spray calcium channel antagonist with 18+ year patent exclusivity; core revenue driver in early commercialization.
Help build intelligence for Milestone Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.